M. Hou

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Yang Wang, Yang Wang, Y. Nan, 2022, Journal of hepatocellular carcinoma.

Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B

J. Shang, Y. Nan, Xiaoxiao Zhang, 2022, Journal of clinical and translational hepatology.

Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling.

Lu Li, Y. Nan, Lingdi Liu, 2021, Histology and histopathology.

Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population

Y. Nan, H. Du, Lu Li, 2023, Journal of International Medical Research.

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis

Y. Nan, Suxian Zhao, Rong Ai, 2023, Lipids in Health and Disease.